Case Studies

Most with long-term diagnosis foud to continue to secrete low levels of insulin… In a large-population based study, researchers used sensitive C-peptide assays to demonstrate that 43-74% people with longstanding (>5 years) type 1 diabetes are microsecretors of endogenous insulin with C-peptide levels. The Scottish researchers measured the occurrence of …

There is some level of risk of CVD events that would result in a positive trade-off of benefit and risk for the use of aspirin, but the precise level of risk is remains uncertain….

As Americans face growing health and financial burdens from preventable, non-communicable diseases such as CV disease, diabetes and cancers, a new study shows employers have a unique opportunity to improve employees’ health…. Dr. Katherine Tryon and Dr. Derek Yach from the Vitality Institute led the study, which involved a first-of-its-kind …

By studying identical twins, researchers have identified mechanisms that could be behind the development of type 2 diabetes…. The study involved 14 pairs of identical twins in Sweden and Denmark. One of each twin had type 2 diabetes while the other was healthy. Emma Nilsson, the researcher who carried out …

A Novo Nordisk drug, IDegLira which combines its long-acting insulin degludec with its type 2 diabetes treatment Victoza, maintained superior blood sugar reduction after one year…. 

A 6-year lifestyle intervention decreased the incidence of diabetes, cardiovascular mortality, and all-cause mortality in adults with impaired glucose tolerance…. 

The American Heart Association questions the findings of a new analysis suggesting that most people around the world are consuming just the right amount of sodium…. 

Metformin plus Cycloset shows significant CVD risk reduction for type 2 diabetes patients in trial….

Weight gain from intensive glucose-lowering treatment is more likely in patients….

Have eggs come back in favor except for those with diabetes?…